| Trial ID: | L2206 |
| Source ID: | NCT00633425
|
| Associated Drug: |
Glimepiride
|
| Title: |
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: GLIMEPIRIDE
|
| Outcome Measures: |
Primary: Change in interstitial glucose levels between the observation and maintenance phases., The mean of 24 variations in average hourly glucose readings recorded by CGMS. | Secondary: HbA1c and fasting blood glucose levels., Measured in the observation and maintenance phases, and change between the two phases.
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
43
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-10
|
| Completion Date: |
2003-10
|
| Results First Posted: |
|
| Last Update Posted: |
2008-03-28
|
| Locations: |
Sanofi-Aventis, Paris, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00633425
|
